Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/26/14 → 09/26/15 |
Funding
- Pharmacyclics: $5,000.00
A Multicenter, Open-Label, Phase 2, Safety and Efficacy Study of the Bruton's Tryosine Kinase (Btk) Inhibitor, PCI-32765, in Subjects with Relapsed or Refractory de Novo Diffuse Large B-Cell Lymphoma
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Wood, Sylvia K (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
- Masood, Aisha (CoPI)
Project: Research